Mission
THE MISSION OF THE OSTEOSARCOMA INSTITUTE IS TO DRAMATICALLY INCREASE TREATMENT OPTIONS AND SURVIVAL RATES IN OSTEOSARCOMA PATIENTS THROUGH IDENTIFYING AND FUNDING THE MOST PROMISING AND BREAKTHROUGH OSTEOSARCOMA CLINICAL TRIALS AND SCIENCE.
Executive compensation, broken down
Form 990 · Schedule J · 1 reported individual · Filing year 2024
Base salaryBonusOther compensationBenefits
| Base salary | Bonus | Other compensation | Benefits | Executive compensation | |
|---|---|---|---|---|---|
Institute Director key employee $231k | |||||
Plus 5 unpaid individuals.
Down 4%
from 2023
From $241k in 2023 to $231k in 2024.
$241k
2023
$231k
2024
$241k
2023
$231k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
1
Texas Health Research & Education Institute2023
$476k
2
THE KIDNEY CANCER ASSOCIATION2023
$367k
3
FOUNDATION FOR ANGELMAN SYNDROME2024
$286k
4
THE OSTEOSARCOMA INSTITUTE2024
$231k
5
COALITION FOR NATIONAL TRAUMA RESEARCH2024
$230k
6
DALLAS VA RESEARCH CORPORATION2022
$64k
Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.